 SAN DIEGO, Feb. 09, 2022 GLOBE NEWSWIRE -- Crinetics Pharmaceuticals Nasdaq: CRNX, a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors, today announced that company management will participate in a fireside chat at the annual SVB Leerink Global Healthcare Conference, which is being held in a virtual format February 14-18, 2022. 